Post

New research · Urology
The French journal of urology · 2d
Cohort studyThe French journal of urology · 2026

Study of risk factors of early reintervention after prostate laser photovaporization using Greenlight 180 W-XPS.

C Hakim, N Hermieu, N Stivalet … I Ouzaid
Read paper
UrologyCohort study

High laser energy density is linked to significantly lower reintervention odds.

Study of risk factors of early reintervention after prostate laser photovaporization using Greenlight 180 W-XPS.

C Hakim et al. · The French journal of urology · 2026
Background

Greenlight laser prostate photovaporization (PVP) is an alternative treatment for benign prostatic hyperplasia.

Purpose

The aim of our study was to identify the risk factors for reintervention due to recurrent obstruction within 12 months following a photovaporization.

Methods

This retrospective, multicenter cohort study include patients treated with laser Greenlight 180W-XPS.

n = 777 patients
Results

Beyond 4000 J/ml, the odds of reintervention are 90% lower.

OR by subgroup · 95% CI
null = 1
age
0.92
laser usage time
0.10
energy delivered/prostate volume
0.66
reduction is greater beyond an energy
0.10
More results

Groups were comparable on preoperative data.

These factors were associated with a reduced risk of reintervention.

“
Conclusion · 1 of 2

PVP shows a low complication rate. Our results suggest that the energy delivered and the laser emission time are predictive of the quality of treatment.

Conclusion · 2 of 2

Despite uncertainties regarding this technique, our findings provide urologists with additional confidence in its use and offer predictive factors for assessing treatment's quality.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Review
31.0 months
Combination therapy meant a longer time before the cancer got worse
Study
100% sensitivity and specificity for L. longbeachae
The ImmuView test correctly identified all L. longbeachae infections and those without it
Cohort Study
98%
98% of patients had no significant rectocele after laparoscopic double sacrocolpopexy.
Cohort Study
SIR 1.67
young bladder cancer survivors have a higher risk of developing second cancers compared to the general population
Randomized Trial
HR 0·55
adding SBRT to systemic therapy lowered the risk of death